Antibiotics linked to higher triple-negative breast cancer death risk
Triple-negative breast cancer patients who take antibiotics within three years of diagnosis have a higher death risk, researchers report.
Stay updated with breaking news from Ami Bhatt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Triple-negative breast cancer patients who take antibiotics within three years of diagnosis have a higher death risk, researchers report.
Women with triple-negative breast cancer who received multiple antibiotic prescriptions within three years after their cancer diagnosis were more likely to experience disease recurrence and to die from their cancer than those who took fewer courses of the drugs, according to a study by researchers at Stanford Medicine.
This review will document what is known about the science and impacts of Long COVID, the lessons that should have been drawn from previous post-viral illnesses and the refusal of world capitalism to address this massive and ongoing social catastrophe.
Experts aren't sure if the fungi affect the disease's progression
Scientists discovered traces of fungi lurking in the tumors of people with different types of cancer, including breast, colon, pancreatic, and lung cancers.